Breaking News Instant updates and real-time market news.

WEN

Wendy's

$15.63

0.24 (1.56%)

, MCD

McDonald's

$173.35

-0.2 (-0.12%)

15:41
12/14/17
12/14
15:41
12/14/17
15:41

Chanos says he'd short almost all fast food stocks, except McDonald's

While being interviewed on CNBC, famed short-seller Jim Chanos said he is not short McDonald's (MCD), but that he is short a number of other fast food restaurant operators. He then discussed issues at a top franchisee of Restaurant Brands (QSR), the owner of Burger King and Tim Hortons. Chanos added: "I'd be short about any one else in the fast food industry besides McDonald's." Other companies that own or franchise fast food restaurant concepts include Wendys (WEN), Yum! Brands (YUM), Jack in the Box (JACK) and Sonic (SONC).

WEN

Wendy's

$15.63

0.24 (1.56%)

MCD

McDonald's

$173.35

-0.2 (-0.12%)

QSR

Restaurant Brands

$61.49

0.16 (0.26%)

YUM

Yum! Brands

$82.12

-0.07 (-0.09%)

JACK

Jack in the Box

$102.49

-0.09 (-0.09%)

SONC

Sonic

$28.32

0.38 (1.36%)

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

WEN Wendy's
$15.63

0.24 (1.56%)

11/08/17
STFL
11/08/17
NO CHANGE
Target $18
STFL
Buy
Wendy's post-earnings pullback a buying opportunity, says Stifel
Stifel analyst Chris O'Cull said he recognizes that Wendy's (WEN) Q3 results may have been worse than McDonald's (MCD) achieved, but its "absolute 3Q results" do not indicate the company is off track, he tells investors. The company's same-restaurant sales miss was largely related to hurricanes and its operating margin contraction was due to an unexpected beef price spike that has already started to subside, he added. The analyst, who views the post-earnings weakness in Wendy's as a buying opportunity, keeps a Buy rating and $18 price target on the stock, which is down 2% to $14.41 in afternoon trading.
10/18/17
LEHM
10/18/17
NO CHANGE
Target $325
LEHM
Equal Weight
Chipotle price target lowered to $325 from $370 at Barclays
Barclays analyst Jeffrey Bernstein lowered his price target for Chipotle Mexican Grill (CMG) to $325 saying he's cautious on the cautious into the Q3 earnings results. Fundamentals for restaurants are increasingly challenged and visibility remains limited, Bernstein tells investors in a research previewing the sector's earnings reports. His best ideas are McDonald's (MCD) followed by Wendy's (WEN) in quick service and Darden (DRI) followed by Bloomin' Brands (BLMN) in casual. The analyst adds that he's "intrigued" by Starbucks (SBUX).
10/13/17
GSCO
10/13/17
NO CHANGE
GSCO
McDonald's 'can outperform for several more years,' says Goldman Sachs
Goldman Sachs analyst Karen Holthouse says historical analysis indicates that McDonald's (MCD) can continue to outperform and gain market share at the expense of regional competitors. According to the analyst, after fast food companies underperform for three quarters, they go on to underperform for an average of 4.6 years. Seven of McDonald's "key competitors...are relatively early in these cycles of underperformance," the analyst wrote. However, Holthouse believes that the risk to Wendy's (WEN) and Restaurant Brands' (QSR) Burger King from McDonald's rebound "may be overstated," since Burger King and Wendy's would only have to gain 30 basis points of share from other fast food players to offset a 5% comp sales gain by McDonald's, according to the analyst. The analyst trimmed her price target on McDonald's to $172 from $174, citing a "modeling error." She cut her price target on Bojangles (BOJA) to $12.50 from $14.50 and lowered her fiscal 2018 comp sales estimates for Bojangles, Dunkin' Brands (DNKN), and Restaurant Brands, citing the latter company's ownership of Popeye's. She sees Bojangle's, Jack in the Box (JACK), and Dunkin Brands as having the most risk, in order from greatest to least, from McDonald's resurgence.
10/11/17
SPHN
10/11/17
DOWNGRADE
Target $14
SPHN
Equal Weight
Bojangles downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Will Slabaugh downgraded Bojangles (BOJA) to Equal Weight from Overweight, saying he expects larger QSR brands with big marketing budgets - such as McDonald's (MCD), Wendy's (WEN) and Restaurant Brands (QSR) - to be the largest beneficiary of macro trends that will negatively impact Bojangles. He lowered his price target on the stock to $14 from $18.
MCD McDonald's
$173.35

-0.2 (-0.12%)

12/05/17
JEFF
12/05/17
UPGRADE
Target $200
JEFF
Buy
McDonald's upgraded to Buy from Hold at Jefferies
Jefferies analyst Andy Barish upgraded McDonald's to Buy from Hold and raised his price target for the shares to $200 from $150. The burger giant closed yesterday down $2.22 to $170.65. McDonald's is well positioned in the current environment to continue to outperform, Barish tells investors in a research note. He believes the company's refranchising transformation and use of data and technology should attract a higher multiple over time, while leading to higher returns. Barish raised his 2018 earnings per share estimate to $6.92 from $6.67 and introduced an above-consensus 2019 estimate of $7.68.
12/05/17
12/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Buy from Hold at Jefferies with analyst Andy Barish saying McDonald's is well positioned in the current environment to continue to outperform. 2. Snap (SNAP) upgraded to Overweight from Equal Weight at Barclays with analyst Ross Sandler sayign with the company's pricing transition in the later stages, Snap may start hitting or exceeding consensus revenue estimates and accelerating growth in 2018. 3. Depomed (DEPO) upgraded to Buy from Neutral at Mizuhom with analyst Irina Koffler citing the company's agreement to license rights to commercialize the Nucynta franchise to Collegium (COLL). 4. United Technologies (UTX) upgraded to Overweight from Neutral at Atlantic Equities. 5. Earthstone Energy (ESTE) upgraded to Buy from Neutral at Seaport Global with analyst Mike Kelly citing the October 18 capital raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/17
FBCO
12/06/17
NO CHANGE
FBCO
Shake Shack, Chipotle among tax reform beneficiaries, says Credit Suisse
Credit Suisse analyst Jason West believes tax reform could have a material impact on restaurant EPS and free cash flow since most profits are generated in the U.S. The analyst sees the top tax reform beneficiaries including Shake Shack (SHAK), Chipotle (CMG), Jack in the Box (JACK), Wingstop (WING), and Dunkin' Brands (DNKN), while companies least-benefited by tax reform tend to be global franchisors with already-low tax rates, such as Restaurant Brands (QSR), McDonald's (MCD) and Yum! Brands (YUM).
12/08/17
LEHM
12/08/17
NO CHANGE
Target $193
LEHM
Overweight
McDonald's price target raised to $193 from $182 at Barclays
Barclays analyst Jeffrey Bernstein raised his price target for McDonald's to $193 following his firm's third annual "Eat, Sleep, Play" conference in New York City. The analyst views the company as a "800lb gorilla" among U.S. restaurants and notes comps for the sector accelerated starting in September. He sees benefits from tax reform providing further support for the restaurant space. The analyst has an Overweight rating on McDonald's.
QSR Restaurant Brands
$61.49

0.16 (0.26%)

12/11/17
EVER
12/11/17
INITIATION
EVER
Outperform
Restaurant Brands initiated with an Outperform at Evercore ISI
Evercore ISI analyst Matt McGinley initiated Restaurant Brands with an Outperform and base case target of $75. The analyst said Restaurant Brands 15%+ earnings growth can span more than a decade with strong brands, diversification, and geography combined with substantial equity appreciation from either buybacks or M&A.
12/06/17
WELS
12/06/17
NO CHANGE
WELS
Tax reform-driven EPS accretion would be sizeable for restaurant sector, says Wells Fargo
Wells Fargo analyst Jeff Farmer says that small cap companies including Del Taco (TACO), Habit Restaurants (HABT), El Pollo Loco (LOCO), Shake Shack (SHAK) and Noodles & Company (NDLS) could see the largest EPS accretion tailwind from a reduced corporate tax rate, with Red Robin (RRGB), Restaurant Brands (QSR), Yum! Brands (YUM) and Bloomin' Brands (BLMN) the companies that could see the smallest tailwind. The analyst notes that recent restaurant sector rally indicates that virtually the entire sector has benefitted from anticipation of potential tax reform, with the most heavily shorted names seeing an amplified share price move.
12/12/17
12/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mylan (MYL), Teva (TEVA) and Endo (ENDP) initiated with a Neutral at Gugenheim, while Impax (IPXL) was initiated with a Buy. 2. Stitch Fix (SFIX) initiated with an Outperform at William Blair, a Neutral at JPMorgan and Goldman Sachs, an Overweight at Piper Jaffray, an Equal Weight at Barclays and a Hold at Stifel. 3. Exxon Mobil (XOM) and ConocoPhillips (COP) initiated with a Neutral at Credit Suisse. The firm also started Range Resources (RRC) and Anadarko (APC) with an Outperform, and Laredo Petroleum (LPI), Energen (EGN), Southwestern Energy (SWN), Noble Energy (NBL), Murphy Oil (MUR), Cabot Oil & Gas (COG) and Newfield Exploration (NFX) with a Neutral rating. 4. Restaurant Brands (QSR) initiated with an Outperform at Evercore ISI. 5. Waste Connections (WCN) initiated with an Outperform, named a top pick at BMO Capital. This list is just a portion of The Fly's full analyst coverage. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
YUM Yum! Brands
$82.12

-0.07 (-0.09%)

12/04/17
BARD
12/04/17
NO CHANGE
BARD
Potential tax cuts should bode well for restaurants, says Baird
Baird analyst David Tarantino argues that with Congress making progress toward passing a tax package that would reduce rates for corporations and individuals, most restaurant chains should benefit from the reform. As such, the analyst sees potential for investor sentiment toward the group to become more positive if tax cuts actually are enacted, creating a good setup for many stocks heading into 2018. Jack in the Box (JACK), El Pollo Loco (LOCO), Wingstop (WING), Dunkin' Brands (DNKN), McDonald's (MCD), Yum! Brands (YUM), Buffalo Wild Wings (BWLD), and Texas Roadhouse (TXRH) seem best positioned to show meaningful step-up in comps following tax cuts, he contends.
11/03/17
UBSW
11/03/17
NO CHANGE
Target $89
UBSW
Buy
Yum! Brands price target raised to $89 from $83 at UBS
UBS analyst Dennis Geiger raised his price target on Yum! Brands to $89 from $83 following Q3 results. The analyst cited ongoing momentum at Taco Bell and KFC, a return to positive same-store-sales at Pizza Hut and solid operating profits. Geiger reiterated his Buy rating on Yum! Brands shares.
JACK Jack in the Box
$102.49

-0.09 (-0.09%)

11/30/17
UBSW
11/30/17
NO CHANGE
Target $105
UBSW
Neutral
Jack in the Box value potential not reflected in shares, says UBS
UBS analyst Dennis Geiger noted Jack in the Box reported Q4 revenue that missed expectations but more importantly did not announce a deal for the sale of Qdoba, which failed to ease investor concerns. He does not think shares entirely reflect the value unlock which could come when a deal is announced. However, he also believes a full valuation inflection isn't likely until Jack demonstrates consistently positive same-store sales. Geiger maintained his Neutral rating and $105 price target on Jack in the Box shares.
11/27/17
BARD
11/27/17
NO CHANGE
Target $115
BARD
Outperform
Jack in the Box risky short-term, good long-term value, says Baird
Baird analyst David Tarantino said Jack in the Box has some risk potential in the short-term as its upcoming Q4 report may be uninspiring with regards to comps and guidance. The analyst believes better fundamentals will emerge and more importantly the ongoing strategic review can act as a catalyst for unlocking long-term shareholder value. Tarantino reiterated his Outperform rating and $115 price target on Jack in the Box shares.
SONC Sonic
$28.32

0.38 (1.36%)

10/06/17
OPCO
10/06/17
NO CHANGE
Target $29
OPCO
Outperform
Sonic outlook to keep shares 'stalled' near term, says Oppenheimer
Oppenheimer analyst Brian Bittner expects Sonic's initial 2018 earnings outlook on October 16 to keep the shares "stalled" i in the near term. The analyst believes 2018 consensus estimates are "skewed a bit aggressively." His estimates are 5% below the Street. Bittner, however, see limited downside risk to Sonic shares without "significant" negative earnings revisions. He keeps an Outperform rating on the stock with a $29 price target.
09/28/17
BARD
09/28/17
NO CHANGE
Target $20
BARD
Neutral
Sonic breach not material risk to processor First Data, says Baird
Baird analyst David Koning believes First Data (FDC) is the card processor for Sonic (SONC), which reported a security breach yesterday. The analyst believes it is possible the franchised locations of Sonic use different processors, so he does not view the breach as a material risk to First Data. Koning maintained his Neutral rating and $20 price target on First Data shares.
09/18/17
SBSH
09/18/17
INITIATION
Target $28
SBSH
Buy
Sonic initiated with a Buy at Citi
Citi analyst Gregory Badishkanian started Sonic Corp. with a Buy rating and $28 price target. The analyst believes the recent share selloff presents a buying opportunity.
09/15/17
COWN
09/15/17
NO CHANGE
Target $25
COWN
Market Perform
Sonic pursuing correct strategy for 2018, says Cowen
Cowen analyst Andrew Charles believes Sonic is pursuing the right strategy for 2018 in enhancing quality and increasing marketing efforts towards the core female customer via non-TV tactics. He does expect industry challenges to persist, but he believes downside is limited by its share repurchase authorization. Charles maintained his Market Perform rating and $25 price target on Sonic shares.

TODAY'S FREE FLY STORIES

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.